Your Heally doctor reviews what you have been taking, your results so far, and your goals, then recommends the right next step at the free consultation
Accessing Retatrutide in Canada Retatrutide remains in clinical trials and lacks Health Canada approval as of 2025
Ready for a New Year jumpstart
Key developments in the vision loss litigation landscape demonstrate rapid evolution: Twenty-one initial petitioners in June 2025 growing to over 30 by August, with cases from 13 different states High-profile individual cases like Todd Engels Maryland lawsuit alleging 90% vision loss in one day without warning Florida resident Delgado v
He found solace and inspiration on TikTok, opening the door to a cheaper drug that he believes in
GLP-1s offer a promising new tool in addressing this challenge, which is why physicians, patients, and policymakers are all paying close attention